Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease.
van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin X, Herring J, Casper C, Kurzrock R.
J Clin Oncol. 2010 Aug 10;28(23):3701-8. Epub 2010 Jul 12.PMID: 20625121 [PubMed - in process]Related citations